Application of cAMP-dependent catalytic subunit β (PRKACB) Low Expression in Predicting Worse Overall Survival: A Potential Therapeutic Target for Colorectal Carcinoma

Conclusion: PRKACB is down-regulated in tumors and associated with worsening OS in CRC patients.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Xiaoya Yao, Weixian Hu, Jie Zhang, Chengzhi Huang, Haibi Zhao, Xueqing Yao Tags: Research Paper Source Type: research